Trial Profile
A Study to Determine the Absolute Bioavailability of YH4808 Using Simultaneous Oral Therapeutic- and [14C]-Labeled Intravenous Microdoses
Status:
Completed
Phase of Trial:
Phase 0
Latest Information Update: 11 Jun 2014
Price :
$35
*
At a glance
- Drugs YH 4808 (Primary) ; YH 4808 (Primary)
- Indications Gastro-oesophageal reflux; NSAID-induced ulcer; Reflux oesophagitis
- Focus Pharmacokinetics
- 17 Apr 2014 According to the ClinicalTrials.gov record, status changed from not yet recruiting to completed.
- 25 Mar 2014 New trial record